Clinical Evidence: What UK Weight Loss Trials Actually Show
UK Weight Loss Results: Wegovy 1mg vs Mounjaro Trial Evidence
Understanding the clinical evidence behind Wegovy 1mg vs Mounjaro requires examining their respective trial programmes and real-world UK outcomes. The STEP clinical trials for Wegovy demonstrated that patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, with results becoming evident around the 1mg dose stage (weeks 9-12). Mounjaro's SURMOUNT trials showed similar efficacy through its dual GIP and GLP-1 receptor mechanism, though direct head-to-head comparisons aren't available due to different trial designs and patient populations.
Both treatments are prescription-only medicines requiring clinical assessment and ongoing medical supervision through our GPhC-registered pharmacy (#9012878). The 1mg Wegovy dose represents a crucial midpoint in the escalation schedule, where many patients begin experiencing significant appetite regulation and measurable weight changes. UK prescribers increasingly recognise that individual response varies, making personalised treatment selection essential for optimal outcomes.
Wegovy 1mg vs Mounjaro Pricing: Complete UK Cost Breakdown
Wegovy 1mg costs £99.99 per pen at EverydayMeds, representing excellent value during the dose escalation phase when appetite suppression typically becomes established. Our Advance Duo bundle (1mg + 1.7mg) is available for £269.99, bridging you smoothly to the next dose level with convenient single-order delivery. New customers can apply code FIRST40 at checkout, while returning patients use DOSE25 to access our competitive pricing structure.
Mounjaro pricing follows a different escalation schedule, starting at £229.99 for the 2.5mg starter dose. When comparing Wegovy 1mg vs Mounjaro across the full treatment journey, consider that Wegovy's gradual dose escalation may suit patients preferring a slower adaptation period. Both treatments require ongoing monthly prescriptions, making our subscription-style ordering process valuable for maintaining consistent supply without repeated assessments.
STEP Trial Evidence: What Wegovy 1mg vs Mounjaro Studies Reveal
The landmark STEP 1 trial published by Wilding et al., NEJM, 2021, demonstrated that Wegovy participants achieved approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions. STEP 5 extended follow-up confirmed sustained results of ~15.2% at 2 years, indicating durability when treatment continues. The SELECT cardiovascular outcomes trial further showed 20% reduction in major cardiovascular events, highlighting benefits beyond weight management.
Mounjaro's SURMOUNT programme demonstrated comparable efficacy through its dual incretin approach, though comparing percentages directly would be misleading due to different baseline populations and study methodologies. Both prescription-only medicines require adherence to reduced-calorie diet and increased physical activity as licensed conditions for optimal effectiveness.
How Wegovy 1mg vs Mounjaro Work: Mechanism Differences Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural fullness hormone produced in your intestines after eating. By the 1mg dose stage, this mechanism typically produces noticeable appetite reduction and enhanced satiety signals, helping you feel satisfied with smaller meal portions. The treatment works directly on brain appetite centres, potentially reducing food cravings and the psychological drive to eat beyond physiological needs. Mounjaro's tirzepatide targets both GLP-1 and GIP receptors simultaneously, creating a dual incretin effect that may influence both appetite and glucose metabolism. Understanding these mechanistic differences helps explain why individual patients may respond differently to each treatment option.
Ordering Process: Getting Wegovy 1mg vs Mounjaro Through EverydayMeds
Our streamlined ordering process begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Qualified prescribers review your application within 3 working days (express 24-hour service available), determining whether Wegovy 1mg vs Mounjaro best suits your circumstances and contraindication profile. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. The assessment covers essential safety screening including family history of thyroid cancer, previous pancreatitis, and current medications that might interact. Our GPhC-registered pharmacy (#9012878) maintains full clinical oversight throughout your treatment journey.
Storage and Practical Considerations: Wegovy 1mg vs Mounjaro Handling
Wegovy offers significant storage advantages over Mounjaro, remaining stable for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. This makes Wegovy more convenient for travel, work schedules, or situations where refrigeration access is limited. The FlexTouch pen delivery system provides precise 1mg dosing with an easy-to-use injection mechanism suitable for weekly self-administration. Both treatments require refrigerated storage at 2-8°C before first use, but Wegovy's extended room temperature stability offers practical advantages for UK patients. The dose escalation schedule means 1mg represents weeks 9-12 of treatment, with progression to 1.7mg and maintenance 2.4mg doses based on tolerance and response.
UK-Specific Wegovy 1mg vs Mounjaro Considerations for Weight Loss
NHS England's updated prescribing guidance recognises both treatments as valuable options for eligible patients, though private prescription remains the most accessible route for most UK residents. The NICE TA875 recommendation for Wegovy emphasises specialist weight management support, which our clinical team provides through ongoing monitoring and dose adjustment guidance. UK prescribing data suggests strong patient preference for Wegovy's gradual dose escalation approach, particularly among those with previous gastrointestinal sensitivity to weight management medications.
Real-world UK outcomes align closely with clinical trial data, with patients typically noticing appetite changes around the 1mg dose stage and measurable weight changes by week 12. Geographic variations in prescribing patterns across England, Scotland, Wales and Northern Ireland reflect different healthcare commissioning approaches, but private prescription access through registered pharmacies ensures consistent availability regardless of postcode.
Making Your Decision: Wegovy 1mg vs Mounjaro Next Steps
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your medical history, lifestyle preferences, and weight management goals. Consider factors like injection frequency (weekly for both), storage requirements, dose escalation schedules, and your previous experience with GLP-1 based treatments when making this important decision. Our clinical assessment process evaluates these factors comprehensively, ensuring you receive the most appropriate prescription for your circumstances. Starting with Wegovy 1mg at £99.99 positions you perfectly in the dose escalation journey, with clear pathways to maintenance dosing based on your individual response and tolerance. Apply discount codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout, and experience the convenience of expert-guided weight management treatment delivered to your door.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
